Intrinsiqs

Is Corvus Pharmaceuticals, Inc. overvalued?

Corvus Pharmaceuticals, Inc. (CRVS) — key valuation metrics and fundamentals.

No verdict
Price
$14.79
Fair value
Current P/E
Normal P/E
Market cap
$1.22B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares CRVS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.